Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07348328
NA

Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery

Sponsor: Nanjing Medical University

View on ClinicalTrials.gov

Summary

This study is a multicenter, randomized controlled, double-blind, placebo-controlled parallel trial designed to evaluate the effect of perioperative supplementation with Compound Vitamin B on patients undergoing cardiovascular surgery. A total of 1,000 patients aged 18-80 years who are scheduled to receive cardiovascular surgeries such as coronary artery bypass grafting (CABG) and valve replacement will be enrolled. They will be randomly assigned at a 1:1 ratio to either the experimental group (perioperative supplementation with Compound Vitamin B tablets, once daily from 3 days before surgery to 6 months after surgery) or the control group (oral placebo), with both groups receiving standardized perioperative treatment.

Official title: Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

1000

Start Date

2026-02-01

Completion Date

2027-12-31

Last Updated

2026-01-16

Healthy Volunteers

No

Interventions

DRUG

Compound Vitamin B tablet

perioperative supplementation with Compound Vitamin B tablets, once daily from 3 days before surgery to 6 months after surgery

DRUG

Control

perioperative supplementation with placebo, once daily from 3 days before surgery to 6 months after surgery

Locations (2)

Shanghai East Hospital Tongji University

Shanghai, DR, China

The First Affiliated Hospital of Nanjing Medical University

Nanjing, China